Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00234676 · ClinicalTrials.gov registry record · Phase 2

POETRY: Study of Estrogen Replacement Therapy in Postmenopausal Women With Parkinson's Disease

A Phase 2 study of Parkinson's Disease, sponsored by The Parkinson Study Group.

Completed
Registry status
Phase 2
Development phase
23
Enrollment target
6
Study locations

NCT00234676 is a Phase 2 study of Parkinson's Disease that has completed, run by The Parkinson Study Group. The registered enrollment target is 23 participants, below the 642-participant average among 156 other Parkinson's Disease trials with a reported enrollment target (96% lower). The trial reports 6 study locations across 6 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00234676, a Phase 2 study of Parkinson's Disease, has completed, sponsored by The Parkinson Study Group.

COMPLETED
Registry status
Phase 2
Development phase
23 participants
Enrollment target
6
Study locations

Study Summary

The primary objectives of the POETRY study are to assess the safety and tolerability of estrogen replacement therapy (ERT) in postmenopausal women with Parkinson's disease (PD) and to assess recruitment for a study of ERT in postmenopausal women with PD.

Conditions Studied

Parkinson's Disease

Interventions

  • DRUG Premarin ®

Study Locations (6)

California

  • The Parkinson's Institute - Sunnyvale

Georgia

  • Emory University - Atlanta

Indiana

  • Indiana University School of Medicine - Indianapolis

Maryland

  • University of Maryland - Baltimore

New York

  • University of Rochester - Rochester

North Carolina

  • Duke University Medical Center - Durham

Trial Details

FieldValue
Enrollment Target 23 participants
Start Date 2003-10
Est. Completion 2006-03
Phase Phase 2

Sponsor

The Parkinson Study Group

2 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00234676

The ClinicalTrials.gov registry entry for NCT00234676 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 642-participant average among 156 other Parkinson's Disease trials with a reported enrollment target (96% lower). The listed sponsor is The Parkinson Study Group, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Parkinson's Disease appearing as the primary indexed condition, and to 1 intervention - of which Premarin ® is the first listed.

NCT00234676 reports 6 study locations spanning 6 distinct geographic areas - top geographies include California, Georgia, Indiana.

Frequently Asked Questions

What is clinical trial NCT00234676 about?

NCT00234676 is a clinical study titled "POETRY: Study of Estrogen Replacement Therapy in Postmenopausal Women With Parkinson's Disease". The primary objectives of the POETRY study are to assess the safety and tolerability of estrogen replacement therapy (ERT) in postmenopausal women with Parkinson's disease (PD) and to assess recruitment for a study of ERT in postmenopausal women with PD.

What is the current status of trial NCT00234676?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 23 participants. The study started on 2003-10. Estimated completion is 2006-03.

What conditions does trial NCT00234676 study?

This clinical trial studies the following conditions: Parkinson's Disease.

What interventions are being tested in trial NCT00234676?

The interventions under investigation include: Premarin ® (DRUG).

Who is sponsoring clinical trial NCT00234676?

This trial is sponsored by The Parkinson Study Group, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00234676 being conducted?

This trial has 6 study locations across California, Georgia, Indiana, Maryland, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Parkinson's Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Parkinson's Disease

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.